Latest Breaking News On - Expanded access program - Page 2 : comparemela.com

Ascendis must wait 3 more months for FDA verdict on TransCon PTH

Ascendis must wait 3 more months for FDA verdict on TransCon PTH
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Austria
Germany
Copenhagen
Køavn
Denmark
United-states
Jan-mikkelsen
Ascendis-pharma
European-commission
Access-program
Expanded-access-program

FDA Extends Review Period for Hypoparathyroidism Treatment TransCon PTH

FDA Extends Review Period for Hypoparathyroidism Treatment TransCon PTH
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.

United-states
Jan-mikkelsen
Ascendis-pharma
Access-program
Drug-administration
New-drug-application
Complete-response-letter
Prescription-drug-user-fee-act
Expanded-access-program

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Norway
Nevan-elam
Christen-baglaneas
Tirtht-patel
Rezolute-inc
Access-program
Securities-exchange
Nasdaq
Chief-executive-officer
Pipeline-progress
Sprague-dawley
Expanded-access-program

Ascendis Pharma (ASND) Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism

Ascendis Pharma (ASND) Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Copenhagen
Køavn
Denmark
Ascendis-pharma
Jan-mikkelsen
Drug-administration
Access-program
New-drug-application
Chief-executive
Expanded-access-program

FDA Extends Review for TransCon PTH in Hypoparathyroidism to August 2024

FDA Extends Review for TransCon PTH in Hypoparathyroidism to August 2024
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Great-britain
Jan-mikkelsen
Ascendis-pharma
Regulatory-agency
Drug-administration
Access-program
Drug-administration-review-of-transcon
European-congress
Chief-executive
Expanded-access-program